explore -WSS

explore

author：Wikipedia 2025-10-01 18:44:07 - browse：854

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： The simple reason for the increase in autism diagnosis

explore

WSS

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

What PEPFAR has meant on the ground in Ukraine

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Illumina to lay off 10% of research and development team

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

focus

explore

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

Radiology is caught between AI's potential and concern for patients

Jerome Adams on the need for new antivirals for Covid

GOP inquiry over gain

Duchenne breakthrough therapy leaves behind pioneering families

Eating disorder hotline's move to chatbot carried cost for volunteers

ChatGPT in medicine: STAT answers readers' burning questions

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Peter Hotez and the public health issue of online harassment

ADA: All diabetes patients should be screened for liver condition

entertainment

SCOTUS to consider access to abortion pill mifepristone

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Leukemia patients are helped by Syndax's new type of therapy

CMS should re

GOP inquiry over gain

Congenital heart disease patients face new threat of heart failure

leisure time

explore

explore

knowledge